메뉴 건너뛰기




Volumn 10, Issue 6, 2004, Pages 611-620

Biotherapy of neuroendocrine gastrointestinal tumors;Biotherapie neuroendokriner gastrointestinaler tumoren

Author keywords

Biotherapy; Carcinoid syndrome; Interferon ; Neuroendocrine gastrointestinal tumor; Somatostatin analogue

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA INTERFERON; ANGIOPEPTIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GASTRIC INHIBITORY POLYPEPTIDE; INTERFERON; OCTREOTIDE; PARACETAMOL; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ALPHA2C INTERFERON; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

EID: 3142709963     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (3)

References (47)
  • 1
    • 0025359399 scopus 로고
    • Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors
    • Andersson T, Wilander E, Eriksson B, Lindgren PG, Oberg K (1990) Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors. Cancer Res 50:3413-3415
    • (1990) Cancer Res , vol.50 , pp. 3413-3415
    • Andersson, T.1    Wilander, E.2    Eriksson, B.3    Lindgren, P.G.4    Oberg, K.5
  • 4
    • 0027235493 scopus 로고
    • Gastroenteropancreatic endocrine tumours: Effect of Sandostatin on tumour growth
    • The German Sandostatin Study Group
    • Arnold R, Benning R, Neuhaus C, Rolwage M, Trautmann ME (1993). Gastroenteropancreatic endocrine tumours: effect of Sandostatin on tumour growth. The German Sandostatin Study Group. Digestion 54 (Suppl 1):72-75
    • (1993) Digestion , vol.54 , Issue.SUPPL. 1 , pp. 72-75
    • Arnold, R.1    Benning, R.2    Neuhaus, C.3    Rolwage, M.4    Trautmann, M.E.5
  • 6
    • 0025913153 scopus 로고
    • Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide
    • Creutzfeldt W, Bartsch HH, Jacubaschke U, Stockmann F (1991) Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. Acta Oncol 30:529-535
    • (1991) Acta Oncol , vol.30 , pp. 529-535
    • Creutzfeldt, W.1    Bartsch, H.H.2    Jacubaschke, U.3    Stockmann, F.4
  • 8
    • 13344295073 scopus 로고    scopus 로고
    • Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group
    • Di Bartolomeo M, Bajetta E, Buzzoni R, Mariani L, Carnaghi C, Somma L, Zilembo N, di Leo A (1996) Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 77:402-408
    • (1996) Cancer , vol.77 , pp. 402-408
    • Di Bartolomeo, M.1    Bajetta, E.2    Buzzoni, R.3    Mariani, L.4    Carnaghi, C.5    Somma, L.6    Zilembo, N.7    Di Leo, A.8
  • 9
    • 0029987910 scopus 로고    scopus 로고
    • Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors-an antiangiogenic effect?
    • Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom (1996) Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors-an antiangiogenic effect? Anticancer Drugs 7:175-181
    • (1996) Anticancer Drugs , vol.7 , pp. 175-181
    • Dirix, L.Y.1    Vermeulen, P.B.2    Fierens, H.3    De Schepper, B.4    Corthouts, B.5    Van Oosterom6
  • 10
    • 0025835971 scopus 로고
    • Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha
    • Doberauer C, Mengelkoch B, Kloke O, Wandl U, Niederle N (1991) Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha. Acta Oncol 30:603-605
    • (1991) Acta Oncol , vol.30 , pp. 603-605
    • Doberauer, C.1    Mengelkoch, B.2    Kloke, O.3    Wandl, U.4    Niederle, N.5
  • 12
    • 0030667438 scopus 로고    scopus 로고
    • High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects
    • Eriksson B, Renstrup J, Imam H, Oberg K (1997) High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects. Ann Oncol 8:1041-1044
    • (1997) Ann Oncol , vol.8 , pp. 1041-1044
    • Eriksson, B.1    Renstrup, J.2    Imam, H.3    Oberg, K.4
  • 13
    • 0043132282 scopus 로고    scopus 로고
    • Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - The International Lanreotide and Interferon Alfa Study Group
    • Faiss S, Pape UF, Bohmig M, Dorffel Y, Mansmann U, Golder W, Riecken EO, Wiedenmann B;International Lanreotide and Interferon Alfa Study Group (2003) Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors - the International Lanreotide and Interferon Alfa Study Group. J Clin Oncol 21:2689-2696
    • (2003) J Clin Oncol , vol.21 , pp. 2689-2696
    • Faiss, S.1    Pape, U.F.2    Bohmig, M.3    Dorffel, Y.4    Mansmann, U.5    Golder, W.6    Riecken, E.O.7    Wiedenmann, B.8
  • 14
    • 0344132653 scopus 로고    scopus 로고
    • Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors
    • Faiss S, Rath U, Mansmann U, Caird D, Clemens N, Riecken EO, Wiedenmann B (1999) Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors. Digestion 60:469-476
    • (1999) Digestion , vol.60 , pp. 469-476
    • Faiss, S.1    Rath, U.2    Mansmann, U.3    Caird, D.4    Clemens, N.5    Riecken, E.O.6    Wiedenmann, B.7
  • 16
    • 0033135279 scopus 로고    scopus 로고
    • Combination therapy with octreotide and alpha-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors
    • Frank M, Klose KJ, Wied M, Ishaque N, Schade-Brittinger C, Arnold R. (1999) Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 94:1381-1387
    • (1999) Am J Gastroenterol , vol.94 , pp. 1381-1387
    • Frank, M.1    Klose, K.J.2    Wied, M.3    Ishaque, N.4    Schade-Brittinger, C.5    Arnold, R.6
  • 17
    • 0025916258 scopus 로고
    • In situ hybridization for detection of hormone and peptide mRNA in carcinoid tumors
    • Funa K (1991) In situ hybridization for detection of hormone and peptide mRNA in carcinoid tumors Acta Oncol 30:457-461
    • (1991) Acta Oncol , vol.30 , pp. 457-461
    • Funa, K.1
  • 18
    • 0025064525 scopus 로고
    • Interferon-induced enhancement of 2′,5′-oligoadenylate synthetase in mid-gut carcinoid tumours
    • Grander D, Oberg K, Lundqvist ML, Janson ET, Eriksson B, Einhorn S (1990) Interferon-induced enhancement of 2′,5′-oligoadenylate synthetase in mid-gut carcinoid tumours. Lancet 336:337-340
    • (1990) Lancet , vol.336 , pp. 337-340
    • Grander, D.1    Oberg, K.2    Lundqvist, M.L.3    Janson, E.T.4    Eriksson, B.5    Einhorn, S.6
  • 19
    • 0037323565 scopus 로고    scopus 로고
    • The pathophysiological consequences of somatostatin receptor internalization and resistance
    • Hofland LJ, Lamberts SW (2003) The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 24:28-47
    • (2003) Endocr Rev , vol.24 , pp. 28-47
    • Hofland, L.J.1    Lamberts, S.W.2
  • 20
    • 0028983495 scopus 로고
    • Interferon-alpha 2b, with or without prior hepatic artery embolization: Clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study
    • Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A (1995) Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study. Scand J Gastroenterol 30:789-796
    • (1995) Scand J Gastroenterol , vol.30 , pp. 789-796
    • Jacobsen, M.B.1    Hanssen, L.E.2    Kolmannskog, F.3    Schrumpf, E.4    Vatn, M.H.5    Bergan, A.6
  • 21
    • 0027241110 scopus 로고
    • Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon
    • Janson ET, Oberg K (1993) Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon. Acta Oncol 32:225-229
    • (1993) Acta Oncol , vol.32 , pp. 225-229
    • Janson, E.T.1    Oberg, K.2
  • 22
    • 0026670264 scopus 로고
    • Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: A randomized trial
    • Janson ET, Ronnblom L, Ahlstrom H, Grander D, Alm G, Einhorn S, Oberg K (1992) Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: a randomized trial. Ann Oncol 3:635-638
    • (1992) Ann Oncol , vol.3 , pp. 635-638
    • Janson, E.T.1    Ronnblom, L.2    Ahlstrom, H.3    Grander, D.4    Alm, G.5    Einhorn, S.6    Oberg, K.7
  • 23
    • 0002959892 scopus 로고    scopus 로고
    • Zollinger-Ellison Syndrome
    • Doherty GM, Skögseid B (eds). Lippincott Williams & Wilkins, Philadelphia
    • Jensen RT (2001) Zollinger-Ellison Syndrome. In: Doherty GM, Skögseid B (eds) Surgical Endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 291-343
    • (2001) Surgical Endocrinology , pp. 291-343
    • Jensen, R.T.1
  • 24
    • 0022510433 scopus 로고
    • Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue
    • Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG (1986) Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 315:663-666
    • (1986) N Engl J Med , vol.315 , pp. 663-666
    • Kvols, L.K.1    Moertel, C.G.2    O'Connell, M.J.3    Schutt, A.J.4    Rubin, J.5    Hahn, R.G.6
  • 25
    • 0024335905 scopus 로고
    • Therapeutic considerations for the malignant carcinoid syndrome
    • Kvols LK (1989) Therapeutic considerations for the malignant carcinoid syndrome. Acta Oncol 28:433-438
    • (1989) Acta Oncol , vol.28 , pp. 433-438
    • Kvols, L.K.1
  • 26
    • 0026041670 scopus 로고
    • The role of somatostatin and its analogs in the diagnosis and treatment of tumors
    • Lamberts SWJ, Krenning EP, Reubi JC (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 12:450-482
    • (1991) Endocrine Rev , vol.12 , pp. 450-482
    • Lamberts, S.W.J.1    Krenning, E.P.2    Reubi, J.C.3
  • 28
    • 0025046253 scopus 로고
    • Antitumor effects of somatostatin mediated by the stimulation of tyrosin-phosphatase
    • Liebow C, Lee MT, Schally A (1990) Antitumor effects of somatostatin mediated by the stimulation of tyrosin-phosphatase. Metabolism 39 (Suppl 2):163-166
    • (1990) Metabolism , vol.39 , Issue.SUPPL. 2 , pp. 163-166
    • Liebow, C.1    Lee, M.T.2    Schally, A.3
  • 29
    • 0024508014 scopus 로고
    • Use of long-acting somatostatin analogue SMS 201-99S in patients with pancreatic islet cell tumors
    • Maton PN, Garnder JD, Jensen RT (1989) Use of long-acting somatostatin analogue SMS 201-99S in patients with pancreatic islet cell tumors. Dig Dis Sci 34:285-291
    • (1989) Dig Dis Sci , vol.34 , pp. 285-291
    • Maton, P.N.1    Garnder, J.D.2    Jensen, R.T.3
  • 30
    • 0024341413 scopus 로고
    • Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon
    • Moertel CG, Rubin J, Kvols LK (1989) Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 7:865-868
    • (1989) J Clin Oncol , vol.7 , pp. 865-868
    • Moertel, C.G.1    Rubin, J.2    Kvols, L.K.3
  • 31
    • 0028269720 scopus 로고
    • Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha
    • Nold R, Frank M, Kajdan U, Trost U, Klose KJ, Arnold R (1994) Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha Z Gastroenterol 32:193-197
    • (1994) Z Gastroenterol , vol.32 , pp. 193-197
    • Nold, R.1    Frank, M.2    Kajdan, U.3    Trost, U.4    Klose, K.J.5    Arnold, R.6
  • 32
    • 0024523620 scopus 로고
    • Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: Development of neutralizing interferon antibodies and possible loss of antitumor activity
    • Öberg K, Alm G, Magnusson A, Lundqvist G, Theodorsson E, Wide L, Wilander E (1989) Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. J Natl Cancer Inst 81:531-535
    • (1989) J Natl Cancer Inst , vol.81 , pp. 531-535
    • Öberg, K.1    Alm, G.2    Magnusson, A.3    Lundqvist, G.4    Theodorsson, E.5    Wide, L.6    Wilander, E.7
  • 33
    • 0025743467 scopus 로고
    • The role of interferons in the management of carcinoid tumors
    • Öberg K, Eriksson B (1991) The role of interferons in the management of carcinoid tumors. Acta Oncol 30:519-522
    • (1991) Acta Oncol , vol.30 , pp. 519-522
    • Öberg, K.1    Eriksson, B.2
  • 35
    • 0026682699 scopus 로고
    • G-protein activation of a hormone stimulated phosphatase in human tumor cells
    • Pan MG, Florio T, Stork PJS (1992) G-protein activation of a hormone stimulated phosphatase in human tumor cells. Science 256:1215-1217
    • (1992) Science , vol.256 , pp. 1215-1217
    • Pan, M.G.1    Florio, T.2    Stork, P.J.S.3
  • 36
    • 0025641087 scopus 로고
    • Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
    • Plöckinger U, Dienemann D, Quabbe HJ (1990) Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly. J Clin Endocrinol Metab 71:1658-1662
    • (1990) J Clin Endocrinol Metab , vol.71 , pp. 1658-1662
    • Plöckinger, U.1    Dienemann, D.2    Quabbe, H.J.3
  • 37
    • 2342651677 scopus 로고    scopus 로고
    • Systemic therapy for metastatic or residual extrapancreatic endocrine tumors
    • Doherty GM, Skögseid B (eds). Lippincott Williams & Wilkins, Philadelphia
    • Plöckinger U, Wiedenmann B (2001) Systemic therapy for metastatic or residual extrapancreatic endocrine tumors. In: Doherty GM, Skögseid B (eds) Surgical Endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 461-476
    • (2001) Surgical Endocrinology , pp. 461-476
    • Plöckinger, U.1    Wiedenmann, B.2
  • 38
    • 0036053655 scopus 로고    scopus 로고
    • Neuroendocrine tumors of the gastro-entero pancreatic GEP system: The role of early diagnosis, genetic testing and preventive surgery
    • Plöckinger U, Wiedenmann B (2002) Neuroendocrine tumors of the gastro-entero pancreatic GEP system: The role of early diagnosis, genetic testing and preventive surgery. Digestive Diseases 20
    • (2002) Digestive Diseases , pp. 20
    • Plöckinger, U.1    Wiedenmann, B.2
  • 39
    • 6044240296 scopus 로고    scopus 로고
    • Treatment of non-functioning gastroenteropancreatic tumors
    • Lamberts SWJ, Dogliotti L (Hrsg). BioScientifica Ltd, Bristol
    • Plöckinger U, Wiedenmann B (2002) Treatment of non-functioning gastroenteropancreatic tumors. In: Lamberts SWJ, Dogliotti L (Hrsg) The Expanding Role of Octreotide I: Advances in Oncology. BioScientifica Ltd, Bristol 113-141
    • (2002) The Expanding Role of Octreotide I: Advances in Oncology , pp. 113-141
    • Plöckinger, U.1    Wiedenmann, B.2
  • 40
    • 0033783951 scopus 로고    scopus 로고
    • Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
    • Ricci S, Antonuzzo A, Galli L, Ferdeghini M, Bodei L, Orlandini C, Conte PF (2000) Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide Ann Oncol 11:1127-1130
    • (2000) Ann Oncol , vol.11 , pp. 1127-1130
    • Ricci, S.1    Antonuzzo, A.2    Galli, L.3    Ferdeghini, M.4    Bodei, L.5    Orlandini, C.6    Conte, P.F.7
  • 41
    • 0024213731 scopus 로고
    • Oncological applications of somatostatin analogues
    • Schally AV (1988) Oncological applications of somatostatin analogues. Cancer Res 48:6977-6985
    • (1988) Cancer Res , vol.48 , pp. 6977-6985
    • Schally, A.V.1
  • 42
    • 0023484084 scopus 로고
    • Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor
    • Smith DB, Scarffe JH, Wagstaff J, Johnston RJ (1987) Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor. Cancer Treat Rep 71:1265-1266
    • (1987) Cancer Treat Rep , vol.71 , pp. 1265-1266
    • Smith, D.B.1    Scarffe, J.H.2    Wagstaff, J.3    Johnston, R.J.4
  • 44
    • 0034105899 scopus 로고    scopus 로고
    • Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR
    • Tomassetti P, Migliori M, Corinaldesi R, Gullo L (2000) Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther 14:557-560
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 557-560
    • Tomassetti, P.1    Migliori, M.2    Corinaldesi, R.3    Gullo, L.4
  • 45
    • 0032173263 scopus 로고    scopus 로고
    • Slow-release lanreotide treatment in endocrine gastrointestinal tumors
    • S. Tomassetti P, Migliori M, Gullo L (1998) Slow-release lanreotide treatment in endocrine gastrointestinal tumors. Am J Gastroenterol 93:1468-1471
    • (1998) Am J Gastroenterol , vol.93 , pp. 1468-1471
    • Tomassetti, S.P.1    Migliori, M.2    Gullo, L.3
  • 46
    • 0026024113 scopus 로고
    • Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
    • Valimaki M, Jarvinen H, Salmela P, Sane T, Sjoblom SM, Pelkonen R (1991) Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer 67:547-549
    • (1991) Cancer , vol.67 , pp. 547-549
    • Valimaki, M.1    Jarvinen, H.2    Salmela, P.3    Sane, T.4    Sjoblom, S.M.5    Pelkonen, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.